Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Argos, the inhibitor of the Drosophila epidermal growth factor (EGF) receptor, remains the only known extracellular inhibitor of this family of receptors in any organism. The functional domain of Argos includes an atypical EGF domain and it is not clear whether it binds to the EGF receptor or if it acts via a distinct receptor to reduce Egfr activity indirectly. Here we present two lines of evidence that strongly suggest that Argos directly interacts with the EGF receptor. First, Argos is unable to inhibit a chimeric receptor that contains an extracellular domain from an unrelated RTK, indicating the need for the EGF receptor extracellular domain. Second, Argos can inhibit the Drosophila EGF receptor even when expressed in human cells, implying that no other Drosophila protein is necessary for inhibition. We also report that Argos and the Drosophila activating ligand, Spitz, can influence mammalian RTK activation, albeit in a cell-type specific manner. This includes the first evidence that Argos can inhibit signalling in mammalian cells, raising the possibility of engineering an effective human EGF receptor/ErbB antagonist. Oncogene (2000) 19, 3560 - 3562

Original publication

DOI

10.1038/sj.onc.1203702

Type

Journal article

Journal

Oncogene

Publication Date

20/07/2000

Volume

19

Pages

3560 - 3562

Keywords

Animals, Carcinoma, Squamous Cell, Culture Media, Conditioned, Drosophila Proteins, Drosophila melanogaster, Enzyme Activation, Epidermal Growth Factor, Eye Proteins, Humans, Insect Proteins, KB Cells, Ligands, MAP Kinase Signaling System, Membrane Proteins, Nerve Tissue Proteins, Phosphorylation, Protein Processing, Post-Translational, Protein Structure, Tertiary, Receptor Protein-Tyrosine Kinases, Receptor, Epidermal Growth Factor, Recombinant Fusion Proteins, Structure-Activity Relationship, Transfection, Tumor Cells, Cultured